What is Sichuan Kelun-Biotech Biopharmaceutical Co Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. Sichuan Kelun-Biotech Biopharmaceutical Co's pretax income for the
three
months ended in Dec. 2023 was HK$0.0 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-358.6 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's pretax margin was %.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sichuan Kelun-Biotech Biopharmaceutical Co Pre-Tax Income Chart
Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data
Trend
Dec21
Dec22
Dec23
Pre-Tax Income
-1,089.53
-633.58
-511.55
Sichuan Kelun-Biotech Biopharmaceutical Co Quarterly Data
Competitive Comparison of Sichuan Kelun-Biotech Biopharmaceutical Co's Pre-Tax Income
For the Biotechnology subindustry, Sichuan Kelun-Biotech Biopharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Kelun-Biotech Biopharmaceutical Co's Pre-Tax Income Distribution in the Biotechnology Industry
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-358.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Pre-Tax Income Explanation
Sichuan Kelun-Biotech Biopharmaceutical Co's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 3 years, Sichuan Kelun-Biotech Biopharmaceutical Co's highest Pretax Margin was -30.36%. The lowest was -2752.92%. And the median was -70.57%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Kelun-Biotech Biopharmaceutical Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06990 has been successfully added to your